Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA

Background Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses. Methodology/Principal Findings DNA was extracted from plasma samples collected from fourteen pregnant women carrying singleton fetuses. Hybridization-based targeted sequencing was used to enrich 2 906 single nucleotide polymorphism loci on chr7, chr13, chr18 and chr21. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of both the mother and fetus for each case were genotyped by single nucleotide polymorphism microarray analysis. For the targeted regions, the mean sequencing depth of the enriched samples was 225-fold higher than that of the non-enriched samples. From the targeted sequencing data, the ratio between fetus-specific and shared alleles increased by approximately 2-fold on chr21 in the paternally-derived trisomy 21 case. In comparison, the ratio is decreased by approximately 11% on chr21 in the maternally-derived trisomy 21 cases but with much overlap with the ratio of the euploid cases. Computer simulation revealed the relationship between the fetal DNA proportion, the number of informative alleles and the depth of sequencing. Conclusions/Significance Targeted massively parallel sequencing of single nucleotide polymorphism loci in maternal plasma DNA is a potential approach for trisomy 21 detection. However, the method appears to be less robust than approaches using non-polymorphism-based counting of sequence tags in plasma.

[1]  S. Antonarakis.  Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group. , 1991, The New England journal of medicine.

[2]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[3]  T K Lau,et al.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.

[4]  L. Poon,et al.  Clinical Chemistry 47:9 1607–1613 (2001) Molecular Diagnostics and Genetics Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma , 2001 .

[5]  K. C. Chan,et al.  Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. , 2005, Clinical chemistry.

[6]  A. Benachi,et al.  Impact of formaldehyde on the in vitro proportion of fetal DNA in maternal plasma and serum. , 2005, Clinical chemistry.

[7]  W. Holzgreve,et al.  Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. , 2005, Clinical chemistry.

[8]  C. Ding,et al.  Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. , 2006, Clinical chemistry.

[9]  Z. Alfirevic,et al.  Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling: A Systematic Review , 2007, Obstetrics and gynecology.

[10]  Sarah E. Emche,et al.  A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study , 2007, The Lancet.

[11]  Charles R Cantor,et al.  Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection , 2007, Nature Medicine.

[12]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[13]  J. Dungan.  A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study , 2008 .

[14]  Anne E Carpenter,et al.  Visualization of image data from cells to organisms , 2010, Nature Methods.

[15]  K. Frazer,et al.  Microdroplet-based PCR amplification for large scale targeted sequencing , 2009, Nature Biotechnology.

[16]  S. Nelson,et al.  DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study , 2011, Genetics in Medicine.

[17]  P. Flegg.  Beyond the valley of the dolls? , 2011, BMJ : British Medical Journal.

[18]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[19]  Gary J. W. Liao,et al.  Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. , 2011, Clinical chemistry.

[20]  H. Cuckle,et al.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. , 2012, Obstetrics and gynecology.